Full name
OPTOMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
86.90.E - Healthcare
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 22,6 | 30,2 | 18,5 | -38,7 |
EBITDA | 23 | 30,3 | 18,6 | -38,6 |
Short time liabilities | 3,8 | 4,1 | 2,6 | -36,8 |
Equity capital | 55,9 | 62,9 | 52,2 | -17 |
Operating profit (EBIT) | 23 | 30,3 | 18,6 | -38,6 |
Assets | 59,8 | 67 | 54,8 | -18,2 |
Net profit (loss) | 20,6 | 27,5 | 16,9 | -38,7 |
Cash | 12,4 | 30,2 | 18,2 | -39,7 |
Net income from sale | 63,4 | 72,8 | 50,9 | -30,2 |
Liabilities and provisions for liabilities | 3,8 | 4,1 | 2,6 | -36,8 |
Working assets | 59,8 | 67 | 54,8 | -18,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 36,8 | 43,8 | 32,3 | -11,5 |
Equity capital to total assets | 93,6 | 93,9 | 95,3 | 1,4 |
Gross profit margin | 35,7 | 41,5 | 36,4 | -5,1 |
EBITDA Margin | 36,2 | 41,6 | 36,6 | -5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 22 | 21 | 19 | -2 |
Current financial liquidity indicator | 15.69103717803955 | 16.342622756958008 | 21.15409278869629 | 4,9 |
Net dept to EBITDA | -0.5403009653091431 | -0.9971477389335632 | -0.9800805449485779 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane